RSV and pneumococci: recommendations for risk groups

In addition to the known risks of respiratory syncytial virus (RSV) infections in newborns, infants and young children, it has recently emerged thatS RSV also poses significant health risks for older adults – especially those with certain underlying conditions. In Switzerland, however, only the vaccination for pregnant women and infants is currently covered by health insurance. In contrast, another, higher-valent pneumococcal conjugate vaccine has been available for the ≥65 age group since fall 2024.